Two-Step TB Skin Testing: When Is It Appropriate?
The two-step tuberculin skin test is appropriate for serial tuberculin testing programs (such as healthcare worker screening at baseline) but should NOT be used for TB contact investigations. 1
Key Clinical Contexts
When Two-Step Testing IS Appropriate:
Serial tuberculin testing programs routinely administer a two-step test at entry into the program 1. This specifically applies to:
- Healthcare workers at baseline/upon hire - The two-step method is recommended when repeated tuberculin testing is anticipated 2, 3. All healthcare workers should have a documented baseline two-step TST upon hire 3
- Persons entering longitudinal TB surveillance programs where future testing will occur 2
The rationale: The two-step procedure detects "boosting" of waned tuberculin sensitivity and prevents misclassifying future positive results as new infections 1. In individuals with remote M. tuberculosis infection or BCG vaccination, delayed-type hypersensitivity can wane over time. A subsequent TST can restore this responsiveness (the "booster phenomenon"), which could be mistaken for recent infection if only single-step testing is used 1.
The method: Persons with a negative initial TST undergo a second tuberculin test 1-3 weeks after the first. The second test result should be considered the "correct" baseline result 2.
When Two-Step Testing Should NOT Be Used:
TB contact investigations - The two-step procedure typically should NOT be used for testing contacts 1. A contact whose second test result is positive after an initial negative result should be classified as recently infected, not as a booster 1.
Important distinction: For contacts, the follow-up testing at 8-10 weeks after exposure ends is NOT a two-step test—it's post-exposure testing to account for the window period of tuberculin reactivity 1. A negative test obtained <8 weeks after exposure is unreliable for excluding infection 1.
Common Pitfalls to Avoid
Do not confuse two-step baseline testing with post-exposure serial testing - These serve different purposes. Two-step testing identifies boosters at baseline; post-exposure testing detects new infections 1
Boosting is particularly common in:
Low-priority TB contacts - A single skin test at the end of the window period is preferred, as a positive second test would more likely represent boosting rather than recent infection 1
Evidence Quality Considerations
The guidelines are consistent across multiple CDC/NTCA recommendations 1 and ATS/CDC standards 2. Research studies support the utility of two-step testing in healthcare workers, showing 2.5-2.8% boosted reactions at baseline 4, 5, with one study demonstrating an 8-fold reduction in false conversions after implementing two-step baseline testing 4.
The clinical impact: Without two-step baseline testing in serial testing programs, boosted reactions on subsequent annual testing could be misinterpreted as new TB infections, leading to unnecessary treatment and inflated conversion rates 4.